R&D 56: Understanding the dynamics of China’s medicine regulatory environment
2015 Activities Schedule
Key considerations for quality HTA submissions; from Wang et al, ISPOR 2015.
Slide of the Month Archive •>
© 2015 CIRS (Centre for Innovation in Regulatory Science)